Your browser doesn't support javascript.
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams, Rory M C; Kim, Brian D; Markantone, Desiree M; Reilly, Kaitlin; Paniz-Mondolfi, Alberto E; Gitman, Melissa R; Choo, S Yoon; Tse, Winona; Robinson-Papp, Jessica.
  • Abrams RMC; Division of Neuromuscular Diseases and Clinical Neurophysiology Laboratories, Department of Neurology, Icahn School of Medicine, Mount Sinai Hospital, 1468 Madison Avenue, New York, NY, 10029, USA. Rory.Abrams@mssm.edu.
  • Kim BD; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Markantone DM; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Reilly K; Division of Neurocritical Care, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Paniz-Mondolfi AE; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gitman MR; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Choo SY; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tse W; Division of Movement Disorders, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Robinson-Papp J; Division of Neuromuscular Diseases and Clinical Neurophysiology Laboratories, Department of Neurology, Icahn School of Medicine, Mount Sinai Hospital, 1468 Madison Avenue, New York, NY, 10029, USA.
J Neurovirol ; 26(5): 797-799, 2020 10.
Article in English | MEDLINE | ID: covidwho-1070964
ABSTRACT
There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and GBS are pathophysiologically related, what biomarkers are useful for diagnosis, and what is the optimal treatment given the medical comorbidities, complications, and simultaneous infection. We report a patient who developed severe GBS following SARS-CoV-2 infection at the peak of the initial COVID-19 surge (April 2020) in New York City and discuss diagnostic and management issues and complications that may warrant special consideration in similar patients.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Guillain-Barre Syndrome / Betacoronavirus / Hyponatremia Type of study: Case report Topics: Long Covid Limits: Aged / Female / Humans Country/Region as subject: North America Language: English Journal: J Neurovirol Journal subject: Neurology / Virology Year: 2020 Document Type: Article Affiliation country: S13365-020-00884-7

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Guillain-Barre Syndrome / Betacoronavirus / Hyponatremia Type of study: Case report Topics: Long Covid Limits: Aged / Female / Humans Country/Region as subject: North America Language: English Journal: J Neurovirol Journal subject: Neurology / Virology Year: 2020 Document Type: Article Affiliation country: S13365-020-00884-7